Stent selection and concomitant antithrombotic strategies are the key considerations when finding the best balance between these opposite threats. Drug-eluting stents should be avoided or strictly ...

[Image from the SpyGlass Pharma website] SpyGlass Pharma released 18-month follow-up data highlighting the potential of its intraocular lens (IOL)-based drug delivery platform. Data came from a ...

Drugs such as Novo Nordisk’s blockbuster Ozempic can cut drug and alcohol abuse by up to 50% according to a new study, adding to mounting evidence that the drugs yield health benefits beyond ...

Established in 1993 by Dhirajlal Kotadia, SMT currently holds a 31 per cent share of the drug-eluting stent (DES) market in India and has been expanding its presence in Europe. In FY24, the company ...

Finally, Dr. Eagle discusses short-term dual antiplatelet therapy (DAPT) after drug-eluting stenting in patients with acute coronary syndrome (ACS).